Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANCE: DOAC vs VKA After Cardiac Surgery
NCT04284839Phase 3Recruiting
- Sponsor
- Population Health Research Institute
- Start
- Jul 2021
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Population Health Research Institute. Started Jul 2021; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04284839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04284839.